- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 9, 2025 | 31.04M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 31.04M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 30.64M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $7K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$3.54M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$6.77M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $7.96M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $11.01M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $5.35M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $9.13M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $8.3M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $14.78M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $7.67M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $7.71M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $9.41M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $13.18M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $14.36M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $18.35M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.13 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.25 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$0.13 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.25 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $2.58M |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $2.68M |
| Rd Expense | Q1 2025 · Mar 31, 2025 | $1.88M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $4.12M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$4.23M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$7.64M |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$4.14M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | −$6.3M |
| Revenue | Q1 2025 · Mar 31, 2025 | $321K |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $496K |